發送短信 : Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments

           _    _     ______    ______    ______  
  ____    | || | ||  /_____//  /_   _//  /_____// 
 |    \\  | || | ||  `____ `    -| ||-   `____ `  
 | [] ||  | \\_/ ||  /___//     _| ||_   /___//   
 |  __//   \____//   `__ `     /_____//  `__ `    
 |_|`-`     `---`    /_//      `-----`   /_//     
 `-`                 `-`                 `-`